Client News/Details

Snell & Wilmer Represents Contract Development and Manufacturing Organization Drug Delivery Experts in Acquisition by Pace Analytical

July 23, 2021

SAN DIEGO - Snell & Wilmer advised Drug Delivery Experts, LLC (DDE), a San Diego-based contract development and manufacturing organization (CDMO) specializing in complex injectable drug formulations and combination drug-device product development, in its sale to Pace Analytical Life Sciences®, LLC (Pace Analytical), a full-service CDMO. The acquisition is expected to allow Pace Analytical to extend capabilities offered to its growing number of clients requiring services throughout the drug development process while adding expertise on drug-device combination products and extended-release injectable technologies.

“Increasingly, customers are relying on the expertise of Pace to support them throughout their drug development,” said Eric Roman, CEO of Pace Analytical in a company press release. “The acquisition of DDE allows us to further service customers across all stages of the process while bringing innovative technologies to our portfolio, including capabilities for long-acting and complex injectables.” Drug Delivery Experts, LLC is a contract development and manufacturing organization with expertise in small molecules and biologics and offering contract drug product R&D clinical trial materials manufacturing from simple solutions to complex injectable formulations. DDE specializes in supporting parenteral drug products from solutions to particulate systems and long-acting technologies. Projects range from preclinical formulation to clinical supply and commercial product reformulation. 

Bardia Moayedi led the Snell & Wilmer team advising DDE in the sale. The diverse team included Katherine McCaig, Sarah Hibbard and paralegal Justin Ferguson (corporate); Jeffrey D. Morton, Ph.D. and R. Lee Fraley (intellectual property); William Kastin (tax) and Greg Gautam (employee benefits).

Snell & Wilmer’s life science and medical technology lawyers currently represent a diverse client base from the bioscience, pharmaceutical (both prescription and OTC), medical device and healthcare industries, ranging from large publicly-traded organizations to early and mid-stage start-up companies. Clients include manufacturers, distributors, inventors, researchers, venture capitalists, angel investors, engineers, product designers and vendors, in their intellectual property, transactional, litigation and various other legal matters.